Tirofiban is a synthetic nonpeptide antiplatelet agent used to prevent blood clots in patients undergoing percutaneous coronary intervention or at risk of myocardial infarction. It inhibits glycoprotein IIb/IIIa receptors, reducing platelet aggregation. The term denotes a pharmaceutical compound and is used mainly in medical contexts and literature.
Full pronunciation guide
